Clinical Trials Browser

INDUSTRY × Solid Tumor × pemigatinib × Clear all

NCT04258527 2021-07-23

Phase 1 Study of Pemigatinib in Patients With Advanced Malignancies With FGF/FGFR Alterations

Phase 1 Completed

Other solid neoplasm

Solid Tumor